However, if any severe symptoms are experienced, such as significant upper abdominal pain with nausea and vomiting, we recommend urgent evaluation given the possibility of pancreatitis or other more acute conditions
10.1111/anae.16306 (a U.K
Beyond preventing weight regain, regular weekly dosing also helps minimize GLP-1 side effects
Studies tell us that low-carb dieters can be deficient in many vitamins and minerals
During GLP-1associated weight loss, lean-mass changes are typically adaptive and preventable , not degenerative. GLP-1 Body Composition Changes: What Clinical Trials Show About Muscle Loss Clinical trials and body-composition sub-studies of semaglutide and tirzepatide consistently demonstrate: Fat mass accounts for most weight lost during treatment. Lean mass may decrease , particularly without resistance training or adequate protein intake. In many patients, the proportion of lean mass relative to total body weight is preserved or improved , because fat loss exceeds lean loss. Key clinical insight: GLP-1/GIP therapies improve overall body composition by preferentially reducing fat massnot by causing muscle breakdown. Lean mass refers to all the non-fat tissues in the bodyprimarily skeletal muscle , but also organs, bones, connective tissue, and body waterthat support metabolism, movement, and overall physical function
This strategy may help people who are particularly sensitive to GLP-1 medications or who experienced severe side effects on tirzepatide
